Article
The new landscape of retinal gene therapy.
American journal of medical genetics. Part C, Seminars in medical genetics - 1 Sept 2020
Ku Cristy A, Pennesi Mark E
Abstract excerpt
Novel therapeutics for inherited retinal dystrophies (IRDs) have rapidly evolved since groundbreaking clinical trials for LCA due to RPE65 mutations led to the first FDA-approved in vivo gene therapy. Since then, advancements in viral vectors have led to more efficient AAV transduction and developed other viral vectors for gene augmentation therapy of large gene targets. Furthermore, significant developments in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
